Related Experiment Videos
Cancer incidence among pharmaceutical workers
1Department of Occupational and Environmental Medicine, University Hospital, Uppsala, Sweden.
Scandinavian Journal of Work, Environment & Health
|April 1, 1995
Summary
Pharmaceutical workers showed increased cancer risks, particularly for urothelial tumors. Smoking was common but likely not the sole cause of elevated cancer incidence in this occupational cohort.
Area of Science:
- Occupational Health
- Epidemiology
- Oncology
Background:
- A cancer cluster at a pharmaceutical plant prompted an investigation into worker health.
- This study examines cancer incidence among employees exposed to various agents.
Purpose of the Study:
- To determine cancer incidence in laboratory and production workers at a pharmaceutical company.
- To investigate potential links between occupational exposures and specific cancer types.
Main Methods:
- Retrospective cohort study design.
- Inclusion criteria: employees with potential exposure to chemical, pharmacological, or biological agents and at least six months of employment (1960-1990).
- Standardized incidence ratios (SIR) calculated using local county population as reference.
Main Results:
- Overall cancer incidence was comparable to expected rates.
- A subcohort with highest exposure showed a significantly elevated SIR of 3.5 for urothelial tumors.
- Increased risk observed for acute leukemia (SIR 4.5), peritoneum, lip, and pleura cancers, though numbers were small.
Conclusions:
- Pharmaceutical workers exhibited a significant increase in urothelial tumor risk.
- While smoking was prevalent, it likely did not fully explain the observed urothelial tumor risk.
- Further investigation into workplace exposures and cancer links is warranted.